Ebba Biotech

Ebba Biotech provides tools for optotracing an innovative visualization method developed by scientists for scientists. Optotracing as a method has been developed by a team of researchers from Karolinska Institute, KTH Royal Institute of Technology and Linkoping University in Sweden and is a result of many years of cutting-edge nanoscience and organic chemistry research. Use our optotracers/fluorescent tracer molecules to search, detect and visualise macromolecular structures; we offer three product families: Amytracker Amyloids and other protein aggregates. For researchers and physicians to gain a deeper understanding of many neurodegenerative disorders, including Alzheimers disease. EbbaBiolight Bacteria & biofilm. For hospitals and...

Amyloid dyes,neurodegenerative diseases,infection diagnostics,renewable biomaterials,biofilm,bacteria,protein aggregates,prion,biobased materials,fluorescence,microscopy,spectroscopy,carbohydrate,glucans,cellulose,lignin,parkinson,alzheimer,and anti microbial

Ebba biotech operates in the Biotechnology research industry.

Ebba biotech's revenue is 11m - 100m

Ebba biotech has 11 - 50 employees.